Clinical trial
Prospective Observational Study on Intracavernosal Injection of Autologous Adipose Tissue-Derived Stem Cells (ADSC) or Stem Cell-derived Exosomes for the Treatment of Erectile Dysfunction
NCT06605508 is registered in ClinicalTrials.gov with Jumeirah American Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Observational Study on Intracavernosal Injection of Autologous Adipose Tissue-Derived Stem Cells (ADSC) or Stem Cell-derived Exosomes for the Treatment of Erectile Dysfunction
- Lead sponsor
- Jumeirah American Clinic
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- January 10, 2025
- Completion date
- December 31, 2029
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
erectile dysfunction, erectile dysfunction associated with type 2 diabetes mellitus, erectile dysfunction following radical prostatectomy